Dual‐Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression

Nonalcoholic fatty liver disease (NAFLD), ranging from nonalcoholic fatty liver to nonalcoholic steatohepatitis (NASH), is the leading cause of chronic liver diseases. Until now, no medications for NAFLD have been approved by relevant governmental agencies. Dual‐specificity phosphatase 9 (Dusp9) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Ping, Xiang, Mei, Liao, Hua, Liu, Jijun, Luo, Hongbo, Wang, Yayun, Huang, Ling, Chen, Manhua, Xia, Jiahong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590435/
https://www.ncbi.nlm.nih.gov/pubmed/30063256
http://dx.doi.org/10.1002/hep.30198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590435/
https://www.ncbi.nlm.nih.gov/pubmed/30063256
http://dx.doi.org/10.1002/hep.30198

Ejemplares similares